Skip to contentLANGER ROBERT — Design Source, Inc. insider: 188 transactions · InsiderLensLANGER ROBERT
- Director at WYETH · on record since Jan 4, 2006
- Director at SONTRA MEDICAL CORP · on record since May 25, 2006
- Director at MOMENTA PHARMACEUTICALS INC · on record since Jun 16, 2006
- Director at BOSTON LIFE SCIENCES INC /DE · on record since Dec 18, 2006
- Director at ISOLAGEN INC · on record since Sep 29, 2009
- Director at MILLIPORE CORP /MA · on record since Dec 17, 2009
- 10% owner at Design Source, Inc. · on record since Nov 1, 2010
- Director at Federal Services Acquisition CORP · on record since Feb 24, 2012
- Director at BIND Therapeutics, Inc · on record since Sep 19, 2013
- Director at ADVANCED CELL TECHNOLOGY, INC. · on record since Jan 5, 2015
- 10% owner at Cartesian Therapeutics, Inc. · on record since Jun 21, 2016
- Director at Kala Pharmaceuticals, Inc. · on record since Jul 21, 2017
- 10% owner at Kala Pharmaceuticals, Inc. · on record since Jul 21, 2017
- Director at ABRAXAS PETROLEUM CORP · on record since May 10, 2018
- Director at Rubius Therapeutics, Inc. · on record since Jul 18, 2018
- Director at NASTECH PHARMACEUTICAL CO INC · on record since Dec 13, 2018
- Director at Korro Bio, Inc. · on record since Oct 2, 2019
- Director at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
- 10% owner at SQZ Biotechnologies Co · on record since Oct 29, 2020
- Director at Seer, Inc. · on record since Dec 11, 2020
Insider trading activity of LANGER ROBERT
- Transactions on record
- 188
- since Sep 16, 2003
- Open-market buys
- 1
- $25K
- Open-market sells
- 46
- $2.8M
- Companies traded
- 16
- last filing Jul 9, 2025
Figures computed from official regulatory filings — methodology.
Companies where LANGER ROBERT has traded
- Seer, Inc.13 tx · Jul 9, 2025
- NASTECH PHARMACEUTICAL CO INC12 tx · May 7, 2024
- Korro Bio, Inc.8 tx · Aug 19, 2022
- Lyra Therapeutics, Inc.3 tx · May 6, 2020
- Rubius Therapeutics, Inc.14 tx · $421.7K · Oct 17, 2019
- Kala Pharmaceuticals, Inc.2 tx · Jun 15, 2018
- BIND Therapeutics, Inc5 tx · $6.6K · Aug 30, 2016
- ADVANCED CELL TECHNOLOGY, INC.15 tx · $433.5K · Feb 11, 2016
- Federal Services Acquisition CORP18 tx · Oct 1, 2014
Track record of LANGER ROBERT
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of LANGER ROBERT
Co-insiders of LANGER ROBERT
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
41 tx · $2.1M · Jun 5, 2013
WYETH19 tx · $490.6K · Oct 19, 2009 | Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 9, 2025 | AwardD | 30,500 | 0.00 USD | $0 | SEC |
| Jul 9, 2025 | Award | 20,500 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | Award | 58,178 | 0.00 USD | $0 | SEC |
| May 7, 2024 | AwardD | 7,557 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | AwardD | 34,735 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | Award | 23,443 | 0.00 USD | $0 | SEC |
| May 5, 2023 | AwardD | 6,134 | 0.00 USD | $0 | SEC |
| Feb 3, 2023 | Gift | -703 | 0.00 USD | $0 | SEC |
| Aug 19, 2022 | OtherD | -14,846 | — | — | SEC |
| Aug 19, 2022 | AwardD | 14,846 | — | — | SEC |
| Aug 19, 2022 | OtherD | -14,846 | — | — | SEC |
| Aug 19, 2022 | AwardD | 14,846 | — | — | SEC |
| Jun 23, 2022 | AwardD | 14,846 | 0.00 USD | $0 | SEC |
| Jun 17, 2022 | AwardD | 29,640 | 0.00 USD | $0 | SEC |
| Jun 17, 2022 | Award | 9,945 | 0.00 USD | $0 | SEC |
| May 2, 2022 | ExerciseD | -703 | 0.00 USD | $0 | SEC |
| May 2, 2022 | Exercise | 703 | 0.00 USD | $0 | SEC |
| May 2, 2022 | AwardD | 5,415 | 0.00 USD | $0 | SEC |
| Jan 12, 2022 | OtherD | -327,102 | 0.00 USD | $0 | SEC |
| Jan 12, 2022 | Other | 327,102 | — | — | SEC |
| Jun 22, 2021 | AwardD | 15,000 | 0.00 USD | $0 | SEC |
| Jun 21, 2021 | AwardD | 14,846 | 0.00 USD | $0 | SEC |
| Apr 30, 2021 | AwardD | 4,081 | 0.00 USD | $0 | SEC |
| Apr 30, 2021 | AwardD | 703 | 0.00 USD | $0 | SEC |
| Dec 11, 2020 | AwardD | 18,691 | 0.00 USD | $0 | SEC |